These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30975755)

  • 21. Fingerprint directed scaffold hopping for identification of CCR2 antagonists.
    Nair PC; Sobhia ME
    J Chem Inf Model; 2008 Sep; 48(9):1891-902. PubMed ID: 18763838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arginine 313 of the putative 8th helix mediates Gα
    Markx D; Schuhholz J; Abadier M; Beier S; Lang M; Moepps B
    Cell Signal; 2019 Jan; 53():170-183. PubMed ID: 30321592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A unique ligand-steered strategy for CC chemokine receptor 2 homology modeling to facilitate structure-based virtual screening.
    Jin H; Xia J; Liu Z; Wang XS; Zhang L
    Chem Biol Drug Des; 2021 Apr; 97(4):944-961. PubMed ID: 33386704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural basis for the binding of the membrane-proximal C-terminal region of chemokine receptor CCR2 with the cytosolic regulator FROUNT.
    Esaki K; Yoshinaga S; Tsuji T; Toda E; Terashima Y; Saitoh T; Kohda D; Kohno T; Osawa M; Ueda T; Shimada I; Matsushima K; Terasawa H
    FEBS J; 2014 Dec; 281(24):5552-66. PubMed ID: 25283965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of trisubstituted cyclohexanes as potent CC chemokine receptor 2 (CCR2) antagonists.
    Cherney RJ; Brogan JB; Mo R; Lo YC; Yang G; Miller PB; Scherle PA; Molino BF; Carter PH; Decicco CP
    Bioorg Med Chem Lett; 2009 Feb; 19(3):597-601. PubMed ID: 19131247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elucidation of binding sites of dual antagonists in the human chemokine receptors CCR2 and CCR5.
    Hall SE; Mao A; Nicolaidou V; Finelli M; Wise EL; Nedjai B; Kanjanapangka J; Harirchian P; Chen D; Selchau V; Ribeiro S; Schyler S; Pease JE; Horuk R; Vaidehi N
    Mol Pharmacol; 2009 Jun; 75(6):1325-36. PubMed ID: 19297521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Key determinants of selective binding and activation by the monocyte chemoattractant proteins at the chemokine receptor CCR2.
    Huma ZE; Sanchez J; Lim HD; Bridgford JL; Huang C; Parker BJ; Pazhamalil JG; Porebski BT; Pfleger KDG; Lane JR; Canals M; Stone MJ
    Sci Signal; 2017 May; 10(480):. PubMed ID: 28536301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural Analysis of Chemokine Receptor-Ligand Interactions.
    Arimont M; Sun SL; Leurs R; Smit M; de Esch IJP; de Graaf C
    J Med Chem; 2017 Jun; 60(12):4735-4779. PubMed ID: 28165741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How Does Agonist and Antagonist Binding Lead to Different Conformational Ensemble Equilibria of the κ-Opioid Receptor: Insight from Long-Time Gaussian Accelerated Molecular Dynamics Simulation.
    An X; Bai Q; Bing Z; Zhou S; Shi D; Liu H; Yao X
    ACS Chem Neurosci; 2019 Mar; 10(3):1575-1584. PubMed ID: 30372027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular dynamics simulation of chemokine receptors in lipid bilayer: a case study on C-C chemokine receptor type 2.
    Shahlaei M; Fassihi A; Papaleo E; Pourfarzam M
    Chem Biol Drug Des; 2013 Nov; 82(5):534-45. PubMed ID: 23930622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Closely related, yet unique: Distinct homo- and heterodimerization patterns of G protein coupled chemokine receptors and their fine-tuning by cholesterol.
    Gahbauer S; Pluhackova K; Böckmann RA
    PLoS Comput Biol; 2018 Mar; 14(3):e1006062. PubMed ID: 29529028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of CCR2-binding features in Cytl1 by a CCL2-like chemokine model.
    Tomczak A; Pisabarro MT
    Proteins; 2011 Apr; 79(4):1277-92. PubMed ID: 21322034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different effects of the different natural CC chemokine receptor 2b ligands on beta-arrestin recruitment, Gαi signaling, and receptor internalization.
    Berchiche YA; Gravel S; Pelletier ME; St-Onge G; Heveker N
    Mol Pharmacol; 2011 Mar; 79(3):488-98. PubMed ID: 21088225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of conformational ensembles in ligand recognition in G-protein coupled receptors.
    Niesen MJ; Bhattacharya S; Vaidehi N
    J Am Chem Soc; 2011 Aug; 133(33):13197-204. PubMed ID: 21766860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chapter 12. The use of receptor homology modeling to facilitate the design of selective chemokine receptor antagonists.
    Carter PH; Tebben AJ
    Methods Enzymol; 2009; 461():249-79. PubMed ID: 19480923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spiroindenes and spiroindanes as antagonists of CC chemokine receptor 2: WO 2009023754.
    Carter PH
    Expert Opin Ther Pat; 2010 Feb; 20(2):283-9. PubMed ID: 20100008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CCR2 antagonists.
    Struthers M; Pasternak A
    Curr Top Med Chem; 2010; 10(13):1278-98. PubMed ID: 20536421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of Conformational State Transitions of Class B GPCRs Using Molecular Dynamics.
    Liao C; May V; Li J
    Methods Mol Biol; 2019; 1947():3-19. PubMed ID: 30969408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding site analysis of CCR2 through in silico methodologies: docking, CoMFA, and CoMSIA.
    Kothandan G; Gadhe CG; Madhavan T; Cho SJ
    Chem Biol Drug Des; 2011 Jul; 78(1):161-74. PubMed ID: 21294847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel series of N-(azetidin-3-yl)-2-(heteroarylamino)acetamide CCR2 antagonists.
    Subasinghe NL; Lanter J; Markotan T; Opas E; McKenney S; Crysler C; Hou C; O'Neill J; Johnson D; Sui Z
    Bioorg Med Chem Lett; 2013 Feb; 23(4):1063-9. PubMed ID: 23294701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.